Stemina.com   Posted in    Feb 7th, 2011

Stemina Awarded Second Phase II SBIR

Stemina received a 2 year contract to study biomarkers of teratogenicity and is a Phase II continuation of the original Phase I work performed for the National Science Foundation in 2010.